CSIMarket Company Name, Ticker, Industry, else..
 
Lexaria Bioscience Corp   (NASDAQ: LEXX)
Other Ticker:  
 
 

Lexaria Bioscience Growth Comparisons

Select each growth Category to receive further Information




 
LEXX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 20 % -0.46 % -2.62 % 1.77 %
Q / Q Revenue Growth (Q1 MRQ) -5.4 % -5.04 % -3.98 % -4.71 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -117.28 % 1.31 % -1.39 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 5.84 % -0.11 % -0.58 % 0.46 %
Revenue 5 Year Average Growth 15.1 % 8.88 % 7.99 % 7.56 %


LEXX's Growth Comparisons in II. Quarter 2025




Lexaria Bioscience reported top-line of $ 0 millions in the second quarter 2025, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry fell by -0.46%, while the top-line in the Healthcare sector decreased by -2.62%, and overall market improved by 1.77% from the second quarter 2024.

Top-line fell by -5.4% from the first quarter. Average annual sales growth for Lexaria Bioscience is 15.1%, while S & P 500's average yearly sales increase is 7.56%, including only Businesses with the second quarter 2025 financial results.

LEXX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Total
20 %
-5.4 %


Growth Rates of LEXX's Income in the second quarter 2025


LEXX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - - - 22.73 %
Sequential Operating Income Change (Q1 MRQ) - 135.84 % 99.05 % 1.38 %
Y / Y Operating Income Growth (Q1 TTM) - 170.03 % 362.31 % 5.44 %
Sequential Operating Income Growth (Q1 TTM) - 114.55 % 60.43 % 5.7 %
Operating Income 5 Year Avg. Change - -1.61 % -1.56 % 9.26 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - - - 59.51 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - 289.42 % 228.85 % 16.29 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 162.21 % 328.35 % 22.56 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - 448.95 % 161.04 % 13.52 %
Income from Cont. Ops. 5 Year Avg. Change - -3.56 % -8.44 % 9.1 %

LEXX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - - - 59.32 %
Q / Q Net Income Growth (Q1 MRQ) - 289.42 % 214.33 % 13.67 %
Y / Y Net Income Change (Q1 TTM) - -15.97 % 23.02 % 10.24 %
Sequential Net Income Change (Q1 TTM) - 448.85 % 154.24 % 13.41 %
Net Income 5 Year Avg. Growth - -4.69 % -8.05 % 8.66 %

LEXX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - - - 59.51 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - 286.73 % 228.85 % 16.29 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - 814.73 % - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - 26.57 % 1.65 %
EPS from Cont. Ops. 5 Year Avg. Growth - -12.19 % -8.44 % 9.1 %



LEXX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - - - 9.1 %
Q / Q EPS Net Growth (Q1 MRQ) - 286.73 % 214.33 % 13.67 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - -37.77 % 68.21 % 9.65 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - 22.69 % 1.67 %
EPS Net 5 Year Avg. Change - -4.69 % -8.05 % 8.66 %



Lexaria Bioscience reported bottom-line of $ -0.15 in the second quarter, compare to $ -0.06 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -0.46%, while Healthcare sector decreased by -2.62%, and overall market improved by 59.32%.

the bottom-line fell by -5.4% from the first quarter. Average annual income per share growth for Lexaria Bioscience is 15.1%, while S & P 500's average yearly income per share increase is 8.66%, including only Businesses with the second quarter 2025 earnings.

LEXX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -5.9 % -10.36 % 10.88 %
Sequential Free Cash Flow Change (Q1 MRQ) - -46.62 % -53.05 % -27.62 %
Y / Y Free Cash Flow Change (Q1 TTM) - 4.72 % -2.45 % 7.46 %
Sequential Free Cash Flow Change (Q1 TTM) - -0.92 % -0.91 % 3.01 %
Free Cash Flow 5 Year Avg. Change - 8.85 % 4.76 % 7.47 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - 941.31 % 137.33 % -
Sequential Net Cash Flow Change (Q1 MRQ) - 125.26 % 227.19 % 750.72 %
Y / Y Net Cash Flow Change (Q1 TTM) 23.04 % - 25.3 % -29.86 %
Sequential Net Cash Flow Change (Q1 TTM) - 1176.33 % 4063.79 % -
Net Cash Flow 5 Year Avg. Change - -24.61 % -15.81 % 0.25 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -100 % -3.29 % -15.04 % 7.11 %
Sequential Capital Expenditures Change (Q1 MRQ) -100 % -46.66 % -39.52 % -12.91 %
Y / Y Capital Expenditures Change (Q1 TTM) -41.62 % -1.14 % -7.47 % 13.95 %
Sequential Capital Expenditures Change (Q1 TTM) -32.9 % -0.62 % -3.11 % 1.64 %
Capital Expenditures 5 Year Avg. Change -24.51 % 9.17 % 7.76 % 7.79 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com